Table 3 Adverse events according to the adjunctive immunosuppressants
Treatment (n) | Adverse events (n) |
|---|---|
MMF (26) | 23% (6) |
GI signs (3), Infection (1) lethargy (1), Anemia (1) | |
Cyclosporin (18) | 55.5% (10) |
GI signs (7), Infection (1), Anemia (1), Thrombocytopenia (1) | |
Leflunomide (16) | 37.5% (6) |
GI signs (2), Anemia (4) | |
Cytarabine (19) | 36.8% (7) |
GI signs (5), Lethargy (1), Infection (n = 2) | |
MMF + Cytarabine (9) | 66.6% (6) |
GI signs (2), Infection (1), Anemia (4) | |
MMF + Cyclosporin (2) | 50% (1) |
GI sign (1) | |
Cyclosporin + Cytrabine (1) | - |